BD VERITOR SYSTEM FOR RAPID DETECTION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) kit by BD Diagnostics BD Diagnostics announced that it has received clearance from the FDA for nasopharyngeal wash, aspirate, ...
Becton, Dickinson and Co. (BD) said today that it acquired its partner and key supplier in developing the BD Veritor™ System, privately held Alverix, in a $40 million deal designed to grow BD’s ...
FRANKLIN LAKES, N.J., Sept. 30, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 ...
MISSISSAUGA, ON, Nov. 10, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 antigen ...
BD Veritor System for Rapid Detection of RSV Receives 510(k) Clearance for Nasopharyngeal Wash, Aspirate and Swab in Transport Media Specimens SAN JOSE, Calif.--(BUSINESS WIRE)-- Alverix, Inc., a ...
BD (Becton, Dickinson and Company) (NYSE: BDX) has announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor™ Plus System has been CE marked to the IVD Directive (98/79/EC) ...
Medical technology major Becton, Dickinson and Company (BDX) revealed that it has received 510(k) clearance and Clinical Laboratory Improvement Amendments (:CLIA) waiver from the U.S. Food and Drug ...
SAN JOSE, Calif.--(BUSINESS WIRE)--Alverix announced today that BD (Becton, Dickinson and Company) has received approval from the Japanese Ministry of Health, Labour, and Welfare (MHLW) for the BD ...
As the world continues to have a need for COVID-19 testing, BD offers a reliable rapid antigen COVID-19 testing solution through the BD Veritor™ System for Rapid Detection of SARS-CoV-2*. This ...
BD VERITOR SYSTEM FOR RAPID DETECTION OF FLU A + B by BD Diagnostics BD Diagnostics announced that it has received clearance from the FDA for nasopharyngeal wash, aspirate, and swab in transport media ...
MISSISSAUGA, ON, Nov. 10, 2020 /CNW/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 antigen test ...